135 related articles for article (PubMed ID: 15457096)
1. p53 protein expression and TP53 mutations in malignant melanomas of sun-sheltered mucosal membranes versus chronically sun-exposed skin.
Ragnarsson-Olding B; Platz A; Olding L; Ringborg U
Melanoma Res; 2004 Oct; 14(5):395-401. PubMed ID: 15457096
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes.
Ragnarsson-Olding BK; Karsberg S; Platz A; Ringborg UK
Melanoma Res; 2002 Oct; 12(5):453-63. PubMed ID: 12394187
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of p53 overexpression in cutaneous melanoma from sun-exposed and nonexposed sites.
Essner R; Kuo CT; Wang H; Wen DR; Turner RR; Nguyen T; Hoon DS
Cancer; 1998 Jan; 82(2):309-16. PubMed ID: 9445187
[TBL] [Abstract][Full Text] [Related]
4. Mutation and expression of TP53 in malignant melanomas.
Weiss J; Heine M; Arden KC; Körner B; Pilch H; Herbst RA; Jung EG
Recent Results Cancer Res; 1995; 139():137-54. PubMed ID: 7597286
[TBL] [Abstract][Full Text] [Related]
5. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin.
Jiveskog S; Ragnarsson-Olding B; Platz A; Ringborg U
J Invest Dermatol; 1998 Nov; 111(5):757-61. PubMed ID: 9804334
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis.
Zerp SF; van Elsas A; Peltenburg LT; Schrier PI
Br J Cancer; 1999 Feb; 79(5-6):921-6. PubMed ID: 10070891
[TBL] [Abstract][Full Text] [Related]
7. Absence of BRAF mutations in UV-protected mucosal melanomas.
Edwards RH; Ward MR; Wu H; Medina CA; Brose MS; Volpe P; Nussen-Lee S; Haupt HM; Martin AM; Herlyn M; Lessin SR; Weber BL
J Med Genet; 2004 Apr; 41(4):270-2. PubMed ID: 15060100
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutation and expression in naevi and melanomas.
Sparrow LE; Soong R; Dawkins HJ; Iacopetta BJ; Heenan PJ
Melanoma Res; 1995 Apr; 5(2):93-100. PubMed ID: 7620345
[TBL] [Abstract][Full Text] [Related]
9. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression.
Poremba C; Yandell DW; Metze D; Kamanabrou D; Böcker W; Dockhorn-Dworniczak B
Oncol Res; 1995; 7(7-8):331-9. PubMed ID: 8747596
[TBL] [Abstract][Full Text] [Related]
11. Overexpression and mutations of p53 in metastatic malignant melanomas.
Hartmann A; Blaszyk H; Cunningham JS; McGovern RM; Schroeder JS; Helander SD; Pittelkow MR; Sommer SS; Kovach JS
Int J Cancer; 1996 Jul; 67(3):313-7. PubMed ID: 8707401
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the functional integrity of the p53 tumor-suppressor gene in malignant melanoma.
Knopf A; Plettenberg C; Pickhard A; Bas M; Reifenberger J; Bier H; Balz V
Melanoma Res; 2011 Oct; 21(5):380-8. PubMed ID: 21691232
[TBL] [Abstract][Full Text] [Related]
13. Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization.
Glatz-Krieger K; Pache M; Tapia C; Fuchs A; Savic S; Glatz D; Mihatsch M; Meyer P
Virchows Arch; 2006 Sep; 449(3):328-33. PubMed ID: 16523260
[TBL] [Abstract][Full Text] [Related]
14. Somatic activation of KIT in distinct subtypes of melanoma.
Curtin JA; Busam K; Pinkel D; Bastian BC
J Clin Oncol; 2006 Sep; 24(26):4340-6. PubMed ID: 16908931
[TBL] [Abstract][Full Text] [Related]
15. Is there more than one road to melanoma?
Rivers JK
Lancet; 2004 Feb; 363(9410):728-30. PubMed ID: 15005091
[TBL] [Abstract][Full Text] [Related]
16. p53 in cutaneous melanoma: immunoreactivity and correlation with prognosis.
Lee CS; Pirdas A; Lee MW
Australas J Dermatol; 1995 Nov; 36(4):192-5. PubMed ID: 8593106
[TBL] [Abstract][Full Text] [Related]
17. Distinct sets of genetic alterations in melanoma.
Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet radiation drives mutations in a subset of mucosal melanomas.
Mundra PA; Dhomen N; Rodrigues M; Mikkelsen LH; Cassoux N; Brooks K; Valpione S; Reis-Filho JS; Heegaard S; Stern MH; Roman-Roman S; Marais R
Nat Commun; 2021 Jan; 12(1):259. PubMed ID: 33431815
[TBL] [Abstract][Full Text] [Related]
19. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
Sedghizadeh PP; Williams JD; Allen CM; Prasad ML
Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678
[TBL] [Abstract][Full Text] [Related]
20. Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type.
Akslen LA; Monstad SE; Larsen B; Straume O; Ogreid D
Int J Cancer; 1998 Feb; 79(1):91-5. PubMed ID: 9495365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]